Stephen Baxter
Stock Analyst at Wells Fargo
(3.80)
# 2,071
Out of 4,662 analysts
701
Total ratings
50.3%
Success rate
4.3%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMRI Lumexa Imaging Holdings | Maintained: Buy | $19 | $11.85 | +60.34% | 4 | Aug 14, 2026 | |
| OSCR Oscar Health | Rated: Hold | $20 → $27 | $32.30 | -16.41% | 32 | Aug 13, 2026 | |
| CAH Cardinal Health | Rated: Buy | $256 → $277 | $234.85 | +17.95% | 22 | Aug 12, 2026 | |
| COR Cencora | Rated: Buy | $331 → $395 | $317.10 | +24.57% | 23 | Aug 11, 2026 | |
| CVS CVS Health | Rated: Buy | $123 | $93.65 | +31.34% | 50 | Aug 11, 2026 | |
| MCK McKesson | Rated: Hold | $812 → $933 | $853.71 | +9.29% | 26 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Rated: Buy | $28 → $40 | $34.77 | +15.04% | 11 | Aug 11, 2026 | |
| MDLN Medline | Rated: Hold | $47 → $34 | $33.91 | +0.27% | 5 | Aug 11, 2026 | |
| PNTG The Pennant Group | Rated: Buy | $45 → $46 | $39.14 | +17.53% | 12 | Aug 10, 2026 | |
| AGL agilon health | Maintained: Buy | $141 → $146 | $93.64 | +55.92% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $369 → $381 | $407.05 | -6.40% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $166 | $172.33 | -3.67% | 35 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 | $59.33 | +31.47% | 23 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $305 → $307 | $277.45 | +10.65% | 40 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $231 → $281 | $268.52 | +4.65% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $502 | $378.02 | +32.80% | 61 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $220 | $201.17 | +9.36% | 54 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $397 → $526 | $388.61 | +35.35% | 51 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $391 → $473 | $398.45 | +18.71% | 49 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $56 → $69 | $64.70 | +6.65% | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $2.92 | -31.51% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $6.66 | +20.12% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $40 | $12.40 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $330.44 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $608.27 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $241.76 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $290.00 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $249.28 | n/a | 1 | Nov 14, 2019 |
Lumexa Imaging Holdings
Aug 14, 2026
Maintained: Buy
Price Target: $19
Current: $11.85
Upside: +60.34%
Oscar Health
Aug 13, 2026
Rated: Hold
Price Target: $20 → $27
Current: $32.30
Upside: -16.41%
Cardinal Health
Aug 12, 2026
Rated: Buy
Price Target: $256 → $277
Current: $234.85
Upside: +17.95%
Cencora
Aug 11, 2026
Rated: Buy
Price Target: $331 → $395
Current: $317.10
Upside: +24.57%
CVS Health
Aug 11, 2026
Rated: Buy
Price Target: $123
Current: $93.65
Upside: +31.34%
McKesson
Aug 11, 2026
Rated: Hold
Price Target: $812 → $933
Current: $853.71
Upside: +9.29%
Concentra Group Holdings Parent
Aug 11, 2026
Rated: Buy
Price Target: $28 → $40
Current: $34.77
Upside: +15.04%
Medline
Aug 11, 2026
Rated: Hold
Price Target: $47 → $34
Current: $33.91
Upside: +0.27%
The Pennant Group
Aug 10, 2026
Rated: Buy
Price Target: $45 → $46
Current: $39.14
Upside: +17.53%
agilon health
Aug 10, 2026
Maintained: Buy
Price Target: $141 → $146
Current: $93.64
Upside: +55.92%
Aug 3, 2026
Rated: Hold
Price Target: $369 → $381
Current: $407.05
Upside: -6.40%
Aug 3, 2026
Maintained: Hold
Price Target: $166
Current: $172.33
Upside: -3.67%
Aug 3, 2026
Maintained: Buy
Price Target: $78
Current: $59.33
Upside: +31.47%
Jul 31, 2026
Rated: Hold
Price Target: $305 → $307
Current: $277.45
Upside: +10.65%
Jul 31, 2026
Rated: Buy
Price Target: $231 → $281
Current: $268.52
Upside: +4.65%
Jul 29, 2026
Rated: Buy
Price Target: $502
Current: $378.02
Upside: +32.80%
Jul 28, 2026
Maintained: Hold
Price Target: $235 → $220
Current: $201.17
Upside: +9.36%
Jul 17, 2026
Rated: Buy
Price Target: $397 → $526
Current: $388.61
Upside: +35.35%
Jul 16, 2026
Rated: Buy
Price Target: $391 → $473
Current: $398.45
Upside: +18.71%
Jul 13, 2026
Maintained: Hold
Price Target: $56 → $69
Current: $64.70
Upside: +6.65%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $2.92
Upside: -31.51%
Oct 29, 2025
Maintained: Hold
Price Target: $8
Current: $6.66
Upside: +20.12%
May 1, 2024
Maintained: Hold
Price Target: $4 → $40
Current: $12.40
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $330.44
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $608.27
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $241.76
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $290.00
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $249.28
Upside: n/a